NCT05142696
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05142696
Title A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ISR | GBR | FRA | ESP | DEU | CZE | CAN | AUT

Facility Status City State Zip Country Details
AdventHealth Orlando Florida 32804 United States Details
University Cancer and Blood Center LLC Athens Georgia 30607 United States Details
University of Kentucky Lexington Kentucky 40536 United States Details
St Louis University St Louis Missouri 63104 United States Details
Hackensack University Medical Ctr Hackensack New Jersey 07601 United States Details
University Hospitals Of Cleveland Cleveland Ohio 44106 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Novartis Investigative Site Vienna 1090 Austria Details
Novartis Investigative Site Montreal Quebec H2X 1R9 Canada Details
Novartis Investigative Site Beijing 100036 China Details
Novartis Investigative Site Shanghai 200032 China Details
Novartis Investigative Site Olomouc 779 00 Czechia Details
Novartis Investigative Site Lille 59000 France Details
Novartis Investigative Site Marseille 13885 France Details
Novartis Investigative Site Montpellier 34298 France Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Beersheba 8457108 Israel Details
Novartis Investigative Site Ramat Gan 5265601 Israel Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Seoul 03722 South Korea Details
Novartis Investigative Site Seoul 05505 South Korea Details
Novartis Investigative Site Barcelona 08035 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Málaga 29010 Spain Details
Novartis Investigative Site Guildford Surrey GU2 7XX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field